Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 18731573 | BIOPSY NEEDLE VISUALIZATION | June 2024 | April 2025 | Allow | 10 | 1 | 0 | No | No |
| 18526806 | SYSTEM AND METHOD FOR MAGNETIC RESONANCE ELASTOGRAPHY | December 2023 | August 2024 | Allow | 9 | 0 | 0 | No | No |
| 18382982 | INTEGRATION OF MULTIPLE DATA SOURCES FOR LOCALIZATION AND NAVIGATION | October 2023 | February 2025 | Allow | 15 | 2 | 0 | Yes | No |
| 18376855 | PASSIVE AND ACTIVE SENSORS FOR ULTRASOUND TRACKING | October 2023 | December 2024 | Abandon | 15 | 1 | 0 | No | No |
| 18205734 | Ultrasound Bone Registration With Learning-Based Segmentation And Sound Speed Calibration | June 2023 | October 2024 | Allow | 16 | 0 | 0 | Yes | No |
| 18204480 | SYSTEM AND METHOD FOR CONCURRENT VISUALIZATION AND QUANTIFICATION OF BLOOD FLOW USING ULTRASOUND VECTOR FLOW IMAGING | June 2023 | July 2024 | Abandon | 13 | 1 | 0 | No | No |
| 18188308 | Systems and Methods for Localizing a Medical Device Using Symmetric Doppler Frequency Shifts Measured with Ultrasound Imaging | March 2023 | March 2025 | Allow | 24 | 3 | 0 | No | No |
| 17989225 | METHODS FOR TISSUE ANALYSIS, LOCATION DETERMINATION AND THERAPY THEREOF USING OPTICAL RADIATION | November 2022 | December 2024 | Allow | 25 | 4 | 0 | Yes | No |
| 18046196 | METHOD FOR DETECTING AND QUANTITATIVELY ASSESSING CARDIAC DYSSYNCHRONY | October 2022 | February 2024 | Abandon | 16 | 1 | 0 | No | No |
| 17917487 | CONTACTLESS VITAL SIGN MONITORING OF MULTIPLE SUBJECTS IN REAL-TIME | October 2022 | April 2025 | Abandon | 30 | 1 | 0 | No | No |
| 17847630 | ULTRASOUND BASED THREE-DIMENSIONAL LESION VERIFICATION WITHIN A VASCULATURE | June 2022 | June 2024 | Allow | 24 | 4 | 0 | Yes | No |
| 17786049 | DEVICE FOR ADJUSTING BIOPSY ANGLES AND BIOPSY NEEDLE GUIDE | June 2022 | June 2024 | Allow | 24 | 1 | 0 | No | No |
| 17662666 | ACCURACY CHECK AND AUTOMATIC CALIBRATION OF TRACKED INSTRUMENTS | May 2022 | February 2025 | Allow | 34 | 0 | 1 | Yes | No |
| 17686204 | DERIVING CONNECTIVITY DATA FROM SELECTED BRAIN DATA | March 2022 | August 2024 | Allow | 30 | 4 | 1 | Yes | No |
| 17577929 | METHOD FOR RELEASING A SUBSTANCE INTO A SUBJECT USING AN INSERTION ARRANGEMENT (as amended) | January 2022 | May 2024 | Abandon | 28 | 2 | 0 | No | Yes |
| 17573104 | Access Devices, Treatment Devices, and Kits Useful for Performing Treatment under Magnetic Resonance Imaging and Related Methods | January 2022 | September 2024 | Allow | 32 | 2 | 1 | Yes | No |
| 17533299 | TOMOGRAPHY CONVERGENCE-TYPE ORAL SCANNER | November 2021 | April 2024 | Allow | 29 | 1 | 0 | No | No |
| 17526798 | APPARATUS AND METHOD FOR FETAL INTELLIGENT NAVIGATION ECHOCARDIOGRAPHY | November 2021 | November 2024 | Allow | 36 | 2 | 0 | No | No |
| 17609524 | LASER POINTER DEVICE FOR USE IN A LAPROSCOPIC SURGERY PROCEDURE | November 2021 | November 2024 | Abandon | 36 | 1 | 0 | No | No |
| 17498416 | SYSTEMS, DEVICES, AND METHODS FOR ROBOTIC PLACEMENT OF ELECTRODES FOR ANATOMY IMAGING | October 2021 | April 2025 | Allow | 42 | 5 | 0 | Yes | No |
| 17493919 | SURGICAL DEVICES, SYSTEMS, AND METHODS USING FIDUCIAL IDENTIFICATION AND TRACKING | October 2021 | December 2024 | Abandon | 39 | 3 | 0 | Yes | No |
| 17440800 | MEDICAL ARM SYSTEM, CONTROL DEVICE, AND CONTROL METHOD | September 2021 | June 2024 | Abandon | 33 | 1 | 0 | No | No |
| 17438816 | DEVICES, SYSTEMS AND METHODS FOR TISSUE ANALYSIS, LOCATION DETERMINATION AND THERAPY THEREOF USING OPTICAL RADIATION | September 2021 | February 2024 | Abandon | 29 | 4 | 1 | Yes | No |
| 17465046 | ULTRASOUND AND STEREO IMAGING SYSTEM FOR DEEP TISSUE VISUALIZATION | September 2021 | June 2025 | Abandon | 45 | 6 | 0 | Yes | No |
| 17409818 | ENDOSCOPY SYSTEM AND METHOD OF RECONSTRUCTING THREE-DIMENSIONAL STRUCTURE | August 2021 | April 2024 | Abandon | 32 | 3 | 0 | No | No |
| 17431639 | SURGICAL DEVICE FOR TRANSPERINEAL BIOPSY, IN PARTICULAR OF THE PROSTATE, FOR A MOVABLE ARM OF A ROBOT | August 2021 | August 2024 | Allow | 36 | 1 | 0 | Yes | No |
| 17417664 | ULTRASONIC PROBE | June 2021 | January 2025 | Allow | 43 | 5 | 0 | Yes | No |
| 17343907 | ULTRASOUND DIAGNOSTIC APPARATUS, MEDICAL IMAGE PROCESSING APPARATUS, AND MEDICAL IMAGE PROCESSING METHOD | June 2021 | May 2025 | Abandon | 47 | 5 | 0 | No | No |
| 17050343 | SURGICAL NAVIGATION METHOD AND SYSTEM | June 2021 | June 2025 | Abandon | 56 | 3 | 0 | Yes | No |
| 17296680 | MEDICAL SYSTEM, INFORMATION PROCESSING DEVICE, AND INFORMATION PROCESSING METHOD | May 2021 | September 2024 | Abandon | 39 | 1 | 0 | No | No |
| 17315247 | SUPPORT FOR A MEDICAL INTERVENTION | May 2021 | February 2025 | Abandon | 45 | 4 | 0 | Yes | No |
| 17041087 | BIOPSY NEEDLE VISUALIZATION | September 2020 | February 2024 | Allow | 41 | 2 | 1 | Yes | No |
| 16970751 | ULTRASONIC APPARATUS FOR MEDICAL EXAMINATION USING ULTRASONIC WAVES | August 2020 | April 2024 | Allow | 44 | 5 | 0 | Yes | No |
| 16990800 | CONSTRUCTING OR RECONSTRUCTING 3D STRUCTURE(S) | August 2020 | June 2024 | Allow | 46 | 4 | 0 | Yes | No |
| 16934714 | Identifying Anatomical Structures | July 2020 | April 2024 | Abandon | 45 | 2 | 0 | No | No |
| 16960274 | METHODS AND SYSTEMS FOR NEAR INFRARED SPECTROSCOPY | July 2020 | August 2024 | Abandon | 49 | 2 | 0 | No | No |
| 16840434 | GUIDING A NEEDLE USING A RADIOPAQUE CONTOUR | April 2020 | June 2025 | Allow | 60 | 7 | 1 | Yes | No |
| 16818640 | DEVICES, SYSTEMS AND METHODS FOR TISSUE ANALYSIS, LOCATON DETERMINATION AND THERAPY THEREOF USING OPTICAL RADIATION | March 2020 | December 2024 | Allow | 57 | 4 | 1 | Yes | No |
| 16645684 | ULTRASOUND PROBE LOCALIZATION WITH DRIFT CORRECTION | March 2020 | June 2024 | Abandon | 51 | 2 | 0 | No | No |
| 16644133 | AN ULTRASONIC PROBE, AN ULTRASONIC IMAGING SYSTEM AND USE METHOD FOR BIOPSY NEEDLE VISUALIZATION ENHANCEMENT | March 2020 | January 2025 | Abandon | 59 | 6 | 1 | Yes | No |
| 16745660 | Optical Tracking Device With Optically Distinguishable Lines | January 2020 | January 2024 | Allow | 48 | 3 | 0 | Yes | No |
| 16611309 | SUPPORT MEMBER FOR INTRALUMINAL IMAGING DEVICES AND ASSOCIATED DEVICES, SYSTEMS, AND METHODS | November 2019 | January 2024 | Allow | 50 | 4 | 1 | Yes | Yes |
| 16512202 | METHODS AND SYSTEMS FOR IMAGING A NEEDLE FROM ULTRASOUND IMAGING DATA | July 2019 | February 2025 | Allow | 60 | 6 | 1 | Yes | No |
| 16336001 | TIME-SYNCHRONIZED DEEP BRAIN STIMULATION OPTIMIZATION | March 2019 | March 2024 | Allow | 60 | 5 | 0 | Yes | No |
| 16243139 | ULTRASOUND DIAGNOSTIC APPARATUS AND STORAGE MEDIUM | January 2019 | March 2024 | Abandon | 60 | 6 | 0 | Yes | No |
| 16310181 | ACOUSTIC SUB-APERTURE PROCESSING FOR ULTRASOUND IMAGING | December 2018 | February 2024 | Allow | 60 | 6 | 0 | Yes | No |
| 16212760 | PATIENT INTERFACE SYSTEM | December 2018 | July 2024 | Allow | 60 | 3 | 1 | Yes | No |
| 16183835 | ULTRASOUND SYSTEM WITH HIGH FREQUENCY DETAIL | November 2018 | April 2025 | Allow | 60 | 6 | 0 | Yes | Yes |
| 16085877 | SYSTEM AND METHOD FOR MAGNETIC RESONANCE ELASTOGRAPHY | September 2018 | September 2023 | Allow | 60 | 5 | 1 | Yes | Yes |
| 16131562 | ULTRASOUND IMAGING APPARATUS, METHOD OF CONTROLLING THE SAME, AND COMPUTER PROGRAM PRODUCT | September 2018 | March 2025 | Abandon | 60 | 8 | 0 | Yes | No |
| 16068673 | APPARATUS AND COSMETIC METHOD FOR TREATING HYPERHIDROSIS | July 2018 | March 2024 | Abandon | 60 | 6 | 0 | No | Yes |
| 16068671 | METHOD AND SYSTEM FOR POSE CONTROLLED ABLATION | July 2018 | July 2022 | Abandon | 48 | 3 | 0 | No | No |
| 16060473 | CT PERFUSION PROTOCOL TARGETING | June 2018 | November 2024 | Abandon | 60 | 4 | 1 | Yes | Yes |
| 15963618 | STERILE COVERS FOR ULTRASOUND TRANSDUCER | April 2018 | March 2025 | Abandon | 60 | 5 | 1 | No | Yes |
| 15611400 | ULTRASOUND MONITORED CONTINUOUS ANESTHESIA APPARATUS AND METHOD OF USING THE SAME | June 2017 | November 2020 | Allow | 41 | 3 | 0 | No | Yes |
| 15335167 | MULTI-PART MARKER | October 2016 | September 2023 | Allow | 60 | 6 | 0 | Yes | No |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner LANGHALS, RENEE C.
With a 0.0% reversal rate, the PTAB affirms the examiner's rejections in the vast majority of cases. This reversal rate is in the bottom 25% across the USPTO, indicating that appeals face significant challenges here.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 20.0% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the bottom 25% across the USPTO, indicating that filing appeals is less effective here than in most other areas.
⚠ Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.
⚠ Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.
Examiner LANGHALS, RENEE C works in Art Unit 3797 and has examined 55 patent applications in our dataset. With an allowance rate of 54.5%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 43 months.
Examiner LANGHALS, RENEE C's allowance rate of 54.5% places them in the 10% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.
On average, applications examined by LANGHALS, RENEE C receive 3.35 office actions before reaching final disposition. This places the examiner in the 98% percentile for office actions issued. This examiner issues more office actions than most examiners, which may indicate thorough examination or difficulty in reaching agreement with applicants.
The median time to disposition (half-life) for applications examined by LANGHALS, RENEE C is 43 months. This places the examiner in the 4% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.
Conducting an examiner interview provides a +45.5% benefit to allowance rate for applications examined by LANGHALS, RENEE C. This interview benefit is in the 92% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.
When applicants file an RCE with this examiner, 13.0% of applications are subsequently allowed. This success rate is in the 4% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.
This examiner enters after-final amendments leading to allowance in 20.5% of cases where such amendments are filed. This entry rate is in the 18% percentile among all examiners. Strategic Recommendation: This examiner rarely enters after-final amendments compared to other examiners. You should generally plan to file an RCE or appeal rather than relying on after-final amendment entry. Per MPEP § 714.12, primary examiners have discretion in entering after-final amendments, and this examiner exercises that discretion conservatively.
When applicants request a pre-appeal conference (PAC) with this examiner, 100.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 76% percentile among all examiners. Strategic Recommendation: Pre-appeal conferences are highly effective with this examiner compared to others. Before filing a full appeal brief, strongly consider requesting a PAC. The PAC provides an opportunity for the examiner and supervisory personnel to reconsider the rejection before the case proceeds to the PTAB.
This examiner withdraws rejections or reopens prosecution in 60.0% of appeals filed. This is in the 32% percentile among all examiners. Of these withdrawals, 33.3% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner shows below-average willingness to reconsider rejections during appeals. Be prepared to fully prosecute appeals if filed.
When applicants file petitions regarding this examiner's actions, 83.3% are granted (fully or in part). This grant rate is in the 93% percentile among all examiners. Strategic Note: Petitions are frequently granted regarding this examiner's actions compared to other examiners. Per MPEP § 1002.02(c), various examiner actions are petitionable to the Technology Center Director, including prematureness of final rejection, refusal to enter amendments, and requirement for information. If you believe an examiner action is improper, consider filing a petition.
Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 45% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 44% percentile). This examiner issues Quayle actions less often than average. Allowances may come directly without a separate action for formal matters.
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.